Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoltan Herold

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of Clinical Medicine|August 26, 2022
Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?Magdolna Dank, Dorottya Mühl, Magdolna Herold, et al.
Cancers|February 15, 2022
Longitudinal Analysis of 1α,25-dihidroxyvitamin D<sub>3</sub> and Homocysteine Changes in Colorectal CancerDorottya Mühl, Magdolna Herold, Zoltan Herold, et al.
Cancers|July 27, 2022
Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal CancerMiklos Acs, Zoltan Herold, Attila Marcell Szasz, et al.
World Journal of Clinical Cases|June 6, 2022
High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancerZoltan Herold, Magdolna Herold, Gyorgy Herczeg, et al.
Open Medicine (Warsaw, Poland)|January 24, 2022
Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?Gyorgy Herczeg, Aniko Somogyi, Magdolna Herold, et al.
World Journal of Clinical Oncology|January 2, 2026
Ultra-processed foods and dietary habits of oncology patients: Risk factor or survival strategyBalint Madarasz, Mate Adam Balazs, Erzsebet Palfi, et al.
Cancers|February 11, 2023
Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of GlioblastomasAttila Marcell Szasz, Elisabeth Estefanía Arrojo Alvarez, Giammaria Fiorentini, et al.
Endokrynologia Polska|August 29, 2020
Regular chromogranin A monitoring facilitated the early detection of a gastrointestinal neuroendocrine tumour in a patient with type 1 diabetesZoltan Herold, Andrea Uhlyarik, Magdolna Herold, et al.
Medical Sciences (Basel, Switzerland)|March 27, 2026
Survival Difference in Advanced-Stage Cervical and Ovarian Cancer Patients Treated with Concomitant Modulated Electro-Hyperthermia in Comparison to Classic Treatment Modalities: Results of a Pilot Study and Meta-AnalysisIvan Panczel, Magdolna Herold, Erika Borbenyi, et al.
Cancers|August 26, 2022
Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous CounterpartsZoltan Herold, Miklos Acs, Attila Marcell Szasz, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Clinical Medicine|August 26, 2022
Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?Magdolna Dank, Dorottya Mühl, Magdolna Herold, et al.
Cancers|February 15, 2022
Longitudinal Analysis of 1α,25-dihidroxyvitamin D<sub>3</sub> and Homocysteine Changes in Colorectal CancerDorottya Mühl, Magdolna Herold, Zoltan Herold, et al.
Cancers|July 27, 2022
Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal CancerMiklos Acs, Zoltan Herold, Attila Marcell Szasz, et al.
World Journal of Clinical Cases|June 6, 2022
High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancerZoltan Herold, Magdolna Herold, Gyorgy Herczeg, et al.
Open Medicine (Warsaw, Poland)|January 24, 2022
Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?Gyorgy Herczeg, Aniko Somogyi, Magdolna Herold, et al.
World Journal of Clinical Oncology|January 2, 2026
Ultra-processed foods and dietary habits of oncology patients: Risk factor or survival strategyBalint Madarasz, Mate Adam Balazs, Erzsebet Palfi, et al.
Cancers|February 11, 2023
Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of GlioblastomasAttila Marcell Szasz, Elisabeth Estefanía Arrojo Alvarez, Giammaria Fiorentini, et al.
Endokrynologia Polska|August 29, 2020
Regular chromogranin A monitoring facilitated the early detection of a gastrointestinal neuroendocrine tumour in a patient with type 1 diabetesZoltan Herold, Andrea Uhlyarik, Magdolna Herold, et al.
Medical Sciences (Basel, Switzerland)|March 27, 2026
Survival Difference in Advanced-Stage Cervical and Ovarian Cancer Patients Treated with Concomitant Modulated Electro-Hyperthermia in Comparison to Classic Treatment Modalities: Results of a Pilot Study and Meta-AnalysisIvan Panczel, Magdolna Herold, Erika Borbenyi, et al.
Cancers|August 26, 2022
Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous CounterpartsZoltan Herold, Miklos Acs, Attila Marcell Szasz, et al.
Pageof 4